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How Guillain–Barre´ patients experience
their functioning after 1 year
Although several reports describe the patient’s
physical situation 1 year after the onset of Guil-
lain–Barre´ syndrome (GBS), little is known about
how the patient himself views his physical and
social situation. Such knowledge would provide a
better insight into the impact GBS can have on
the life of the patient (1). Also in clinical practice
the patient’s view 1 year after onset is a milestone
in the process of their recovery. Several personal
reports (2, 3) relate how individuals experience the
acute phase of the ascending paralysis and the
period of artificial respiration, and how they cope
with the possibility of prolonged rehabilitation.
Although more attention has been given recently
to the social aspects of immune-mediated neuro-
pathies and especially GBS (4, 5), no systematic
study has reported extensively on the patient’s
personal clinical judgment 1 year after the onset
of GBS.
We studied how a group of patients experienced
their physical and social situation at homecoming
and at 1 year after the onset of GBS.
Material and methods
Study population
The patients participated in the Dutch segment of
an international, multicenter, double-blind, pla-
cebo-controlled trial comparing treatment with
intravenous immunoglobulin (IVIg) 0.4 g/kg
body weight and placebo with treatment of IVIg
combined with methylprednisolone 500 mg/day for
5 consecutive days (6). All patients fulfilled the
NINCDS criteria for GBS, experienced onset of
weakness within 2 weeks and were unable to walk
independently for 10 m. An exclusion criterion in
the present study was age below 16. Patients from
outside the Netherlands were excluded because the
testing material used was only available in Dutch.
All participants signed an informed consent form
with respect to our study, and the ethics committee
of the participating Dutch centers approved the
protocol.
Of the 125 patients who were eligible for the
trial, six did not give informed consent, three
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GBS, 30% did not function at home as well as before and 52% had
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Robert A.J.A.M. Bernsen1,
Aeiko E.J. de Jager2,
Frans G.A. van der Mech3,
Theo P.B.M. Suurmeijer4
1Department of Neurology, Jeroen Bosch Hospital,
s-Hertogenbosch, the Netherlands, 2Department of
Neurology, University Hospital, Groningen, the
Netherlands, 3Department of Neurology, Erasmus
University Medical Center, Rotterdam, the Netherlands,
4Department of Health Sciences/Northern Centre of
Healthcare Research (NCH); Department of Sociology/
Interuniversity Center for Social Science Theory and
Methodology (ICS); University of Groningen, Groningen,
the Netherlands
Key words: Guillain–Barr syndrome; impact; daily life;
perception; functioning; social
Robert A.J.A.M. Bernsen, Department of Neurology,
Jeroen Bosch Hospital, PO Box 90153, 5200 ME
s-Hertogenbosch, The Netherlands
Tel.: +31 73 6992350
Fax: +31 73 6992832
e-mail: r.bernsen@jbz.nl
51
died before the trial was completed, two were
too ill to participate, one suffered from an
other handicap and 23 were lost during follow-
up. A total of 90 patients finished the present
study.
Questionnaire
A self-administered questionnaire was sent to the
patients 12 months after the diagnosis of GBS
was made (7). The questionnaire contained ques-
tions on the patients discharge from one hospital
to another hospital, to a rehabilitation center or
to home. Six questions enquired at the presence
and extent of sensory respectively motor residua
in face/chest, arms and legs at homecoming. The
patient could indicate if no residua were present
(score ¼ 0); only present in fingers (score ¼ 1);
present in hand and fingers (score ¼ 2); present in
arm and hand and fingers (score ¼ 3). Lower
limbs were scored in a similar way. Presence in
face, chest or both resulted in scores of 1, 2 and 3,
respectively. The answers to the six questions on
the physical condition at homecoming were com-
bined to an index, the homecoming index, scores
running from 0 to 18. The index scores were
divided in three groups: normal or mild, scoring
0–6; moderate, scoring 7–12; serious, scoring
13–18. The same six questions were asked on
the physical condition at 12 months, giving the
12-month index. Furthermore, the patients were
asked to appraise the disruptive effect of the
sensory and motor residua of face, arms and legs
at 12 months. The possible answers ranged from
not present, noticeable but not really annoying,
moderately annoying to seriously annoying. The
answers formed the disruption index. The method
of scoring of the 12-month index and the disrup-
tion index was the same as for the homecoming
index.
Other questions dealt with various aspects of
their social condition at 12 months. One set of
questions on employment was used to determine
if the work situation had changed, e.g. the same
job with fewer physical demands or less respon-
sibility, a different job with fewer physical
demands or less responsibility or no job at all.
The specific reasons for GBS-related job changes
were determined, e.g. decrease of power, lasting
sensory changes, lack of condition, mental chan-
ges or other reasons. Other questions dealt with
the changes due to GBS in the housing situation,
in functioning at home and in leisure activities. A
few open questions were added to give the
patients a chance to make further comments or
to elaborate on details.
Physical assessment
At 12 months, the patients were physically assessed
using the Hughes disability scale as a functional
score (8): good recovery [no neurological symp-
toms (F0) or minor neurological symptoms and
signs and capable of running (F1)], moderate
recovery [able to walk 10 m or more without
assistance but unable to run (F2)], or severe residua
[able to walk 10 m across an open space with help
(F3) or bed or chair bound (F4)]. Further possi-
bilities are F5 ¼ requiring assisted ventilation for
at least part of the day and F6 ¼ dead.
General data
Data were available on age at entry, sex, presence
of other diseases, possible artificial respiration
during the disease and the treatment the patient
had received. The general data (except for sex and
age) and the data on the physical assessment were
not made available to us until the data from the
questionnaires of all the patients were collected.
Statistical analyses
The Fisher’s exact test and ANOVA were used to
determine if there was a difference between the
patients who participated in the study and those
who did not. With respect to differences in the final
F-score, a Mann–Whitney test was used.
Chi-square tests/Fisher’s exact test was used to
compare the two treatment groups regarding the
self-perception of their physical and social situ-
ation.
The Wilcoxon signed ranks test was used to
establish the course of the patient’s condition
between the moment of homecoming and
12 months after the diagnosis. Odds ratios were
determined in relation to several aspects of staying
at a rehabilitation center. Logistic regression was
used to study the relation of the indexes of
homecoming, 12 months and disruption to several
social aspects at 12 months.
Results
General information
The group of patients who completed our ques-
tionnaire consisted of 48 men and 42 women,
ranging in age from 16 to 88 years. At entry, 28
patients scored F3, 56 F4 and six F5 (ventilator
dependent). At nadir, 23 patients were ventilator
dependent. After 1 year, 30 patients scored F0, 43
F1, 11 F2, three F3 and two F4 (one missing).
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The patients who completed the questionnaire
were compared to those who refused to participate
and to those who did not participate due to failure
in follow up. No differences were found with
respect to age, sex, artificial respiration, treatment
and F-score.
In our group of patients analysis showed no
difference between those treated with IVIg and
those treated with IVIg and steroids, regarding the
self-perception of their physical and social situ-
ation.
Course
Fifty-six of the 90 patients (62%) were discharged
directly to home after a hospital stay lasting on
average 23 days with a minimum of three and a
maximum of 59 days. Twenty-nine patients (32%)
were discharged directly to a rehabilitation center.
The mean duration of stay in hospital and
rehabilitation center was 131 days, varying from
34 to 273 days. One patient went first to another
hospital and later to a rehabilitation center, two
stayed with family and two went to a nursing
home.
Sensory changes and decrease of power experi-
enced by the patients at homecoming are specified
in Table 1. Up to 72% had sensory disturbances
and loss of power in some part of the arms and up
to 89%, in some part of the legs.
After 1 year, 33% of the patients felt completely
cured, one within 22 days, but with a mean of
230 days after onset of GBS. Nine patients felt that
their improvement had stagnated after a period
lasting from 207 to 315 days (two missing values).
Presence of disturbed sensation and decreased
power, reported by the patients at 12 months, is
presented in Table 1. It appears that a considerable
number of patients still perceived decreased power
and disturbed sensation, in the lower extremities
more than in the upper extremities.
The perceived disrupting effect of disturbed
sensation and decreased power at 12 months is
depicted in Table 2. The sensory disturbances were
reported to be moderately or seriously annoying in
arms (22.2%) and legs (36.6%). Loss of power was
reported to be moderately or seriously annoying in
30% respectively 48.9%.
Muscle ache or cramps were still present in
45.6%. Fifty percent had other residual symptoms.
Fatigue in general was not systematically assessed
for but was mentioned in 17%. Problems with
concentration (4%) were mentioned most fre-
quently among a variety of other symptoms. In
15.6% some form of aid like a cane, a crutch, or
even a wheelchair was used.
A significant improvement can be noted in the
perceived loss of power and sensation between
homecoming and 12 months following onset of
GBS (Table 1). If the hospital stay lasted longer,
the improvement was less significant. Duration of
stay showed a significant correlation with both the
12-month index (P ¼ 0.000, r ¼ 0.39) and the
disruption index (P ¼ 0.000, r ¼ 0.41), but not
with the homecoming index (P ¼ 0.060).
Social aspects after 1 year
Thirty-three of the 90 participants in our study had
already retired before the start of the study. Of the
remaining 57, 18 patients (32%) had changed their
work because of GBS. Only one of these 18
patients had a job on the same level as before,
nine held a job with lesser demands, and eight had
not yet resumed working. Seven were declared
unfit to work for more than 75%. Five were
disabled for a lesser percentage. Lack of physical
condition (10 patients) and loss of power (nine)
were the most frequently mentioned causes of the
work-related problems. Twenty-eight patients had
contacted the company physician; six of them were
not satisfied with the results. One felt the company
Table 1 Percentages of sensory disturbances and loss of power experienced by
the patients at homecoming and 1 year after GBS (n ¼ 90) (Wilcoxon signed ranks
test, one-sided)









Face/chest 38.9 45.6 16.7 24.4 P < 0.001 P < 0.000
Missing values 13.3 15.6 10.0 8.9
Arm/hand/fingers 31.1 55.6 16.7 24.4 P < 0.000 P < 0.000
Hand/fingers 21.1 11.1 10.0 5.6
Fingers 13.3 5.6 8.9 5.6
Missing values 4.4 5.6 6.7 3.3
Leg/feet/toes 50.0 80.0 34.4 54.4 P < 0.000 P < 0.000
Feet/toes 20.0 5.6 15.6 6.7
Toes 8.9 2.2 10.0 6.7
Missing values 4.4 5.6 2.2 1.1
Table 2 Percentage of patients with a perceived disruptive effect with respect
to sensory disturbance and loss of power in face/chest, upper extremity and lower
extremity 1 year after onset of GBS (n ¼ 90)
Perceived effect
Face/chest Upper extremity Lower extremity
Sensation Power Sensation Power Sensation Power
Noticeable, not disrupting 6.7 5.6 14.4 10.0 22.2 16.7
Moderately disrupting 7.8 12.2 14.4 23.3 23.3 30.0
Seriously disrupting 5.6 6.7 7.8 6.7 13.3 18.9
Missing values 7.8 6.7 6.7 2.2 3.3 3.3
Perception of functioning 1 year after GBS
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physician knew too little of the residual status after
GBS, and four patients mentioned they wanted to
return to work but felt restrained by the company
physician. When going back to work, 34 (60%)
first worked part-time.
Inability to function at home as well as before
GBS was mentioned by 27 patients (30%); eight
patients (9%) did not live in the same place or
under the same circumstances as before.
Leisure activities had altered in 47 patients
(52%). Again lack of physical condition (36) and
loss of power (29) were reported to be the main
reasons. Sensory disturbance (13) and mental
changes (four) were less frequently noted.
After 1 year, 39 (43%) were still somewhat
psychologically affected because of GBS and 15
(17%) to a greater degree.
Logistic regression of the homecoming index, the
12-month index and the disruption index in rela-
tion to the change in social aspects, showed that
only the disruption index leads to a change in
leisure activities (R2 ¼ 0.57, B ¼ 0.77, P ¼ 0.013).
Logistic regression of the F-score in relation to
changes in social aspects only leads to a change in
the housing situation.
Rehabilitation center
Patients who had been artificially ventilated were
more often referred to a rehabilitation center [odds
ratio (OR) 5.75, 95% confidence interval (CI)
1.919–17.226]. Patients who had been referred to a
center were less likely to be completely cured (OR
0.082, 95% CI 0.018–0.374), and had more changes
in hobbies (OR 5.431, 95% CI 1.92–15.355), but
not in work and housing circumstances. More of
these patients functioned more poorly at home
than they did before the onset of GBS (OR 0.390,
95% CI 0.154–0.984).
Discussion
A high percentage of patients experienced decrease
in power and sensation at homecoming. Not only
the presence but also the distribution of the
decrease was significant. Up to 89% of the patients
still experienced loss of power, not only in toes or
feet but also, in most cases, even in the legs.
Diminished power in a larger part of an extremity
was present in more patients than sensory distur-
bance. These results signify that the patients and
their family should be very well prepared as to
what to expect on hospital discharge. We found,
however, that these physical residua at homecom-
ing had no effect on the social situation at
12 months.
At 1 year, the patients perceived a clear
improvement compared to homecoming. However,
a considerable number of patients still experienced
both a decrease of power and disturbed sensation.
It is difficult to compare with other studies as these
report about the neurological examination and our
study concentrates on the subjective feelings of the
patients.
In a recently published Swedish study (9), 88%
of patients were fully recovered or showed only
mild residual symptoms or signs on neurological
examination at 1 year. In contrast to this report,
our study suggests that a considerable number of
patients still experience physical residua 1 year
after the onset of GBS, both with respect to the
distribution as well as to the disrupting effect. The
findings of Rees et al. (10) are more in accordance
with our study. It is possible that the discrepancies
in outcome are also the result of a varying
combination of differences in age, severity of
signs and the amount of axonal damage (9, 11).
The loss of power in the legs was perceived as
disrupting to seriously disrupting by almost half of
the patients. Table 2 shows how frequently a
disrupting effect continues to occur even after
1 year. This signifies that it is important not only to
establish the actual presence of loss of power but
also to evaluate the perceived effect.
After 1 year, more than half of the patients
continued to experience improvement. This obser-
vation confirms the findings of Fletcher et al. (12)
who concluded that in a group of mechanically
ventilated patients, improvement might remain
clinically significant well beyond 1 year. In another
group of patients, it was reported that 21% still
noticed improvement after 3–6 years (4). In the
group that felt completely cured, this still took an
average of 230 days, confirming the prolonged
course of improvement a patient has to be
prepared for, even in the most optimal cases.
Patients should be informed clearly about the pace
of recovery in order to prevent both too optimistic
and too pessimistic expectations. This is considered
to be an important aspect of the quality of care
provided to patients (13).
The effect of social aspects on the recovery and
well-being of patients with GBS and other poly-
neuropathies has been receiving increasing atten-
tion (4, 14–17). Although these aspects should
definitely be considered in the long run, important
information came out of the present study at only
1 year after onset of GBS. For example, work had
changed in 32% of our patients and leisure
activities in 52%. That lack of physical condition
and decreased power were the most frequent causes
of these changes confirmed an earlier study (4).
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Familiarity with the problem may enable the
attending physician to be more supportive and
limit or even prevent deterioration of social func-
tioning within the first year after the onset of GBS.
In a recently published report, some items assessing
these aspects are incorporated in a new handicap
scale in immune-mediated polyneuropathies (15).
Comparing the results from our present study
with the results in a group 3–6 years after GBS is
speculative (7). In that group, 38% changed their
work and 37% reported disturbance in functioning
at home, slightly higher percentages than in our
group. It is possible that in the long run, patients
who have not completely recovered cannot keep up
with the demands on their physical condition. That
would explain why lack of physical condition is
frequently mentioned as a problem. Changes in
housing circumstances (15%) occurred more fre-
quently in the group 3–6 years after GBS. This
could suggest that some patients who first return to
their previous housing arrangements would be
forced to move later. Change in leisure activities,
on the other hand, occurred less frequently in the
long-term study (44% compared with 52% in the
present study). It could be possible that after 1 year
some patients are able to catch up with their
previous leisure activities, although it is not known
if they can perform them with the same intensity as
before. These results suggest that not much further
improvement occurs with respect to the social
situation after 1 year. The influence of psychologi-
cal factors as anxiety and depression, as well as the
quality of familial environment needs further
clarification, but was not the objective of this
study.
Logistic regression showed that the present
physical condition as represented by the
12-month index is no evident predictor for changes
in the social aspects studied. However, the per-
ceived disruption of the physical condition is a
predictor for changes in leisure time. This signifies
that not only the physical condition but also its
perceived effect should be considered.
In general, patients discharged to a rehabilit-
ation center had a worse F-score at 12 months and
had more neurological sequelae than patients going
home directly. Nevertheless, the final employment
situation in these patients was comparable to the
situation of patients who went home directly.
Possibly, a stay in a rehabilitation center success-
fully prepares a patient to cope with his work
despite his neurological residua.
It can be concluded that a considerable number
of patients in our study still perceived decrease of
power and sensation with an often disturbing
effect 1 year after onset of GBS. Furthermore,
GBS continued to have an evident impact on
daily life and on social well-being. We agree with
a report by Zifko (17) that a careful neurological
examination should be supplemented by informa-
tion about the patient’s own perception of his
physical condition. This knowledge would enable
the attending physician to better support the
patient’s recovery.
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